130 related articles for article (PubMed ID: 21878388)
1. Drug release control and system understanding of sucrose esters matrix tablets by artificial neural networks.
Chansanroj K; Petrović J; Ibrić S; Betz G
Eur J Pharm Sci; 2011 Oct; 44(3):321-31. PubMed ID: 21878388
[TBL] [Abstract][Full Text] [Related]
2. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction.
Chansanroj K; Betz G
Acta Biomater; 2010 Aug; 6(8):3101-9. PubMed ID: 20132913
[TBL] [Abstract][Full Text] [Related]
3. Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees.
Petrović J; Ibrić S; Betz G; Đurić Z
Int J Pharm; 2012 May; 428(1-2):57-67. PubMed ID: 22402474
[TBL] [Abstract][Full Text] [Related]
4. Application of sucrose fatty acid esters in transdermal therapeutic systems.
Csóka G; Marton S; Zelko R; Otomo N; Antal I
Eur J Pharm Biopharm; 2007 Feb; 65(2):233-7. PubMed ID: 16963242
[TBL] [Abstract][Full Text] [Related]
5. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
[TBL] [Abstract][Full Text] [Related]
6. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.
Park JS; Shim JY; Park JS; Choi YW; Jeong SH
Drug Dev Ind Pharm; 2011 Jun; 37(6):664-72. PubMed ID: 21449708
[TBL] [Abstract][Full Text] [Related]
7. Sustained release of highly water-soluble drugs with micelle forming ability from polyionic matrix tablets.
Tanaka Y; Miyazaki Y; Yakou S; Takayama K
Pharmazie; 2007 Jan; 62(1):41-5. PubMed ID: 17294812
[TBL] [Abstract][Full Text] [Related]
8. Diclofenac release from eudragit-containing matrices and effects of thermal treatment.
Billa N; Yuen KH; Peh KK
Drug Dev Ind Pharm; 1998 Jan; 24(1):45-50. PubMed ID: 15605596
[TBL] [Abstract][Full Text] [Related]
9. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
Fuertes I; Miranda A; Millán M; Caraballo I
Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
[TBL] [Abstract][Full Text] [Related]
10. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets.
Viridén A; Wittgren B; Larsson A
Eur J Pharm Sci; 2009 Feb; 36(2-3):297-309. PubMed ID: 19038336
[TBL] [Abstract][Full Text] [Related]
11. Oxidized konjac glucomannan-cassava starch and sucrose esters as novel excipients for sustained-release matrix tablets.
Liu C; Li J; Li K; Xie C; Liu J
Int J Biol Macromol; 2020 Aug; 156():1045-1052. PubMed ID: 31756473
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical granulation and tablet formulation using neural networks.
Kesavan JG; Peck GE
Pharm Dev Technol; 1996 Dec; 1(4):391-404. PubMed ID: 9552323
[TBL] [Abstract][Full Text] [Related]
13. Study of the effects of drugs on the structures of sucrose esters and the effects of solid-state interactions on drug release.
Szuts A; Makai Z; Rajkó R; Szabó-Révész P
J Pharm Biomed Anal; 2008 Dec; 48(4):1136-42. PubMed ID: 18849134
[TBL] [Abstract][Full Text] [Related]
14. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
[TBL] [Abstract][Full Text] [Related]
15. The influence of API concentration on the roller compaction process: modeling and prediction of the post compacted ribbon, granule and tablet properties using multivariate data analysis.
Boersen N; Carvajal MT; Morris KR; Peck GE; Pinal R
Drug Dev Ind Pharm; 2015; 41(9):1470-8. PubMed ID: 25212638
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets.
Roberts M; Vellucci D; Mostafa S; Miolane C; Marchaud D
Drug Dev Ind Pharm; 2012 Sep; 38(9):1068-76. PubMed ID: 22149472
[TBL] [Abstract][Full Text] [Related]
17. Statistical moments in modelling of swelling, erosion and drug release of hydrophilic matrix-tablets.
Barmpalexis P; Kachrimanis K; Malamataris S
Int J Pharm; 2018 Apr; 540(1-2):1-10. PubMed ID: 29407874
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug.
Al-Saidan SM; Krishnaiah YS; Satyanarayana V; Bhaskar P; Karthikeyan RS
Eur J Pharm Biopharm; 2004 Nov; 58(3):697-703. PubMed ID: 15451547
[TBL] [Abstract][Full Text] [Related]
19. Formulation and in-vitro evaluation of floating bilayer tablet of lisinopril maleate and metoprolol tartrate.
Ijaz H; Qureshi J; Danish Z; Zaman M; Abdel-Daim M; Hanif M; Waheed I; Mohammad IS
Pak J Pharm Sci; 2015 Nov; 28(6):2019-25. PubMed ID: 26639495
[TBL] [Abstract][Full Text] [Related]
20. Study of gel-forming properties of sucrose esters for thermosensitive drug delivery systems.
Szuts A; Budai-Szucs M; Eros I; Otomo N; Szabó-Révész P
Int J Pharm; 2010 Jan; 383(1-2):132-7. PubMed ID: 19748563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
